Federal Supply Schedule V797P5261B

The federal contract IDV award is an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract covers an extensive array of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...

The Office of Logistics and Acquisition Operations established a Blanket Purchase Agreement with Qiagen, LLC on April 10, 2024, for medical and scientific equipment, biological materials, and RNAi items, with a ceiling of $10 million and an ultimate completion date of May 31, 2026. Work is performed at Qiagen's facility in Germantown, Maryland. The BPA procures molecular diagnostics products and laboratory consumables, including DNA/RNA extraction kits, next-generation sequencing equipment,...

Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the National Acquisition Center (a civilian federal agency) on October 7, 2021, for the supply of Diltiazem capsules across four line items. The contract carries a ceiling value of $7.78 million and includes a base performance period from October 7, 2021, through October 6, 2022, followed by four one-year option periods extending the ultimate completion date to October 6, 2026. This award resulted from a...

Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a Defense-focused federal agency, to manufacture and distribute pharmaceutical products. The contract, with a ceiling value of $51.5 million and an ultimate completion date of September 16, 2025, was awarded on September 17, 2020, following a pre-solicitation posted on September 3, 2019. The originating solicitation sought a national requirements contract for...

Mylan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on March 4, 2023, for the supply of clozapine tablets. This contract carries a ceiling value of $8.3 million with an ultimate completion date of December 31, 2026. The initial ordering period runs from March 4, 2023 through March 3, 2024, with four one-year renewal options available thereafter. The pre-solicitation opportunity was posted on August...

Sanofi Vaccines US Inc., a division of Sanofi Pasteur Inc., was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency Troop Support Medical (a defense agency under the Medical Supply Chain) on February 4, 2026, with an ultimate completion date of February 3, 2027. The contract, valued at $13.13 million, procures Injectable Influenza Vaccine for the 2026-2027 flu season in prefilled syringes. The procurement encompasses approximately 3.08 million doses with a...

Golden State Medical Supply, Inc. has been awarded a single-award Indefinite Delivery Contract by the VA National Acquisition Center for the supply of Buprenorphine HCL/Naloxone HCL sublingual tablets to support multiple federal healthcare systems. The contract, valued at $20.98 million, covers the base ordering period from June 8, 2026, through June 7, 2027, with four one-year option periods extending potential contract performance through June 7, 2030. The specific products procured include...

Prasco, LLC, a pharmaceutical manufacturer and distributor headquartered in Mason, Ohio, was awarded a single-award Indefinite Delivery Contract (IDC) by the Medical Supply Chain on June 5, 2024, with a ceiling value of $31.7 million and a performance period extending through June 4, 2034. The contract establishes a framework for the Medical Supply Chain, a defense-focused federal agency, to procure pharmaceutical and medical supply products on an indefinite quantity basis. Under this IDV...

GlaxoSmithKline, LLC has been awarded a multiple-award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) to supply pediatric vaccines for the Vaccines for Children (VFC) program. The contract, valued at $1.49 billion, covers the period from April 1, 2025, through March 31, 2026, with no set-aside designation applied. Under this solicitation, GlaxoSmithKline will manufacture and deliver standard commercial pediatric vaccines to support immunization efforts for...

Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on March 17, 2024, for the supply of Escitalopram Oxalate Tablets in multiple strengths (5mg, 10mg, and 20mg). The contract carries a ceiling value of $48.4 million and establishes a base performance period from March 17, 2024, through March 16, 2025, with four one-year option periods extending through March 16, 2027. The contract was awarded...